Hiroshi Tanaka
- Nephrology top 0.5%
- Renal Diseases and Glomerulopathies 77
- Immunology top 1%
- interferon and immune responses 34
- Immune Response and Inflammation 22
- Urology top 0.5%
- Cancer Research top 1%
- Rheumatology top 0.5%
- Systemic Lupus Erythematosus Research 50
-
- Lung Cancer Treatments and Mutations 42
-
- Lung Cancer Research Studies 20
- Colorectal Cancer Treatments and Studies 18
-
- Chronic Lymphocytic Leukemia Research 18
- Co-authors
- Kaoru MogushiJunta TanakaEtsuro ItoTadaatsu ImaizumiKazushi TsurugaShinobu WagaSuyu ShuHirohisa Yoshizawa
- Cited by
- NephrologyImmunologyUrology
- Journals
- Pediatric Nephrology (15 papers)The Journal of Urology (13 papers)Journal of Clinical Oncology (10 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Hiroshi Tanaka
703 papers receiving 12.8k citations
Hit Papers
Peers
Comparison fields: 5 of 198
- Nephrology 1.1k
- Immunology 2.0k
- Urology 557
- Cancer Research 1.3k
- Rheumatology 1.2k
Countries citing papers authored by Hiroshi Tanaka
This map shows the geographic impact of Hiroshi Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Tanaka more than expected).
Fields of papers citing papers by Hiroshi Tanaka
This network shows the impact of papers produced by Hiroshi Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Tanaka. The network helps show where Hiroshi Tanaka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroshi Tanaka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 1 | |
| 8 | 2021 | 0 | |
| 9 | 2020 | 3 | |
| 10 | 2019 | 2 | |
| 11 | 2019 | 4 | |
| 12 | 2019 | 2 | |
| 13 | 2018 | 17 | |
| 14 | 2017 | 1 | |
| 15 | 2016 | 6 | |
| 16 | 2012 | 8 | |
| 17 | 2011 | 79 | |
| 18 | 2009 | 26 | |
| 19 | Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growthbreakdown → | 2008 | 526 |
| 20 | 1996 | 0 |
About Hiroshi Tanaka
Hiroshi Tanaka is a scholar working on Nephrology, Rheumatology and Immunology, having authored 738 papers that have together received 13.2k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (77 papers), Systemic Lupus Erythematosus Research (50 papers), Lung Cancer Treatments and Mutations (42 papers), interferon and immune responses (34 papers), Immune Response and Inflammation (22 papers), Lung Cancer Research Studies (20 papers), Chronic Lymphocytic Leukemia Research (18 papers) and Colorectal Cancer Treatments and Studies (18 papers). The work is most often cited by research in Nephrology (1.1k citations), Immunology (2.0k citations) and Urology (557 citations). Hiroshi Tanaka has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Kaoru Mogushi, Junta Tanaka, Etsuro Ito, Tadaatsu Imaizumi, Kazushi Tsuruga, Shinobu Waga, Suyu Shu, Hirohisa Yoshizawa, Koji Tsugawa and Koichi Suzuki. Their work appears in journals such as Pediatric Nephrology, The Journal of Urology, Journal of Clinical Oncology, Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.